Filing Manager
22NW Fund, LP
Reporting Manager
22NW Fund, LP
Symbol
LFCR
Shares outstanding
39,346,838 shares
Disclosed Ownership
4,367,499 shares
Ownership
11%
Form type
SCHEDULE 13D/A
Filing time
26 Dec 2024, 13:20:34 UTC
Date of event
23 Dec 2024
Next filing
29 May 2025

Sponsored

Quoteable Key Fact

"22NW Fund, LP disclosed 11% ownership in Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR) on 23 Dec 2024."

Quick Takeaways

  • 22NW Fund, LP filed SCHEDULE 13D/A for Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR).
  • Disclosed ownership: 11%.
  • Date of event: 23 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 26 Dec 2024, 13:20.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
22NW Fund, LP 11% 4,367,499 4,367,499 0 22NW Fund GP, LLC General Partner 0001640809
22NW, LP 11% 4,367,499 4,367,499 0 22NW GP, Inc., General Partner 0001694297
22NW Fund GP, LLC 11% 4,367,499 4,367,499 0 /s/ Aron R. English Manager 0001770575
22NW GP, Inc. 11% 4,367,499 4,367,499 0 /s/ Aron R. English President and Sole Shareholder 0001783663
Aron R. English 11% 4,367,499 4,367,499 0 /s/ Aron R. English Individually and as attorney-in-fact for Nathaniel Calloway 0001770436
Bryson O. Hirai-Hadley 0% 583 583 0 /s/ Bryson O. Hirai-Hadley Bryson O. Hirai-Hadley 0001888106
Nathaniel Calloway 0% 34,315 34,315 0 /s/ Aron R. English As attorney-in-fact for Nathaniel Calloway 0001952771